Tuberculosis
COVID-19, TB coinfection linked to reduced survival
Patients who died of a COVID-19 and tuberculosis coinfection had a shorter median time to death compared with patients who died of either COVID-19 or TB alone, according to results published in European Respiratory Journal.
Therapy choice in rheumatoid arthritis does not impact serious infection risk
Among patients with rheumatoid arthritis, the chosen course of therapy does not have an impact on the risk for developing a serious infection, according to data published in Rheumatology.
Mycobacterial infections rare among people with diabetic foot infections
Clinicians and microbiologists who care for patients with diabetic foot infections may be able to decrease the use of mycobacterial cultures and health care costs because these infections are uncommon, according to study data.
Levofloxacin reduces risk for multidrug-resistant TB in children, adults
Levofloxacin was safe and reduced the risk for multidrug-resistant tuberculosis among children, adolescents and adults by 60% in two phase 3 trials, according to results presented at the Union World Conference on Lung Health.
Top in ID: Novel procedure for lung infection; leftover antibiotics threaten stewardship
The surgical team at Northwestern Medicine placed breast implants in a man’s chest cavity to hold his heart in place as he underwent a double-lung transplant following a month-long infection.
Progress against TB recovers significantly following COVID-19 disruptions, WHO report says
The highest ever reported number of tuberculosis diagnoses was reported in 2022, a feat likely due to the recovery of TB services following the COVID-19 pandemic, according to WHO’s 2023 Global TB report.
Top in ID: Progress with vaccines for mosquito-borne diseases
Healio spoke with several experts to get their feedback on the first two malaria vaccines ever recommended for use and how they will impact the fight against the disease, which threatens half the global population.
Survey: Almost half of providers skip TB testing for high-risk patients
Almost half of health care providers in the United States do not routinely test patients born outside the U.S. for tuberculosis, despite CDC recommendations that say they should, a survey found.
What is the world’s top vaccine priority?
Scientists have successfully developed the first vaccines against malaria and respiratory syncytial virus, but other vaccine targets remain.
In Africa, PEPFAR countries test more for COVID-19, showing impact of investment
BOSTON — Sub-Saharan African countries supported by the U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, tested for COVID-19 at three times the rate of non-PEPFAR nations, according to data presented at IDWeek.